IMMUNOPAK Trademark

Trademark Overview

On Wednesday, April 29, 2020, a trademark application was filed for IMMUNOPAK with the United States Patent and Trademark Office. The USPTO has given the IMMUNOPAK trademark a serial number of 88893297. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Friday, April 4, 2025. This trademark is owned by The Prolmmune Company, L.L.C.. The IMMUNOPAK trademark is filed in the Pharmaceutical Products category with the following description:

Amino acids for medical purpose; Amino acids for medical purposes for physiological synthesis of glutathione and the reduction of oxidative stress; Antivirals; Antivirals for physiological synthesis of glutathione and the reduction of oxidative stress; Pharmaceutical preparations, namely, antivirals; all the foregoing for human use
immunopak

General Information

Serial Number88893297
Word MarkIMMUNOPAK
Filing DateWednesday, April 29, 2020
Status733 - FOURTH EXTENSION - GRANTED
Status DateFriday, April 4, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 7, 2023

Trademark Statements

Goods and ServicesAmino acids for medical purpose; Amino acids for medical purposes for physiological synthesis of glutathione and the reduction of oxidative stress; Antivirals; Antivirals for physiological synthesis of glutathione and the reduction of oxidative stress; Pharmaceutical preparations, namely, antivirals; all the foregoing for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 12, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameThe Prolmmune Company, L.L.C.
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressRhinebeck, NY 12572
Party NameThe Prolmmune Company, L.L.C.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressRhinebeck, NY 12572

Trademark Events

Event DateEvent Description
Wednesday, July 29, 2020NON-FINAL ACTION E-MAILED
Saturday, May 2, 2020NEW APPLICATION ENTERED
Tuesday, May 12, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 23, 2020ASSIGNED TO EXAMINER
Wednesday, July 29, 2020NON-FINAL ACTION WRITTEN
Wednesday, July 29, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, January 29, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 29, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, January 30, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 8, 2021NON-FINAL ACTION WRITTEN
Monday, March 8, 2021NON-FINAL ACTION E-MAILED
Monday, March 8, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 8, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 8, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 9, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 18, 2021NON-FINAL ACTION WRITTEN
Monday, October 18, 2021NON-FINAL ACTION E-MAILED
Monday, October 18, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 18, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 18, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 19, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 8, 2022ASSIGNED TO EXAMINER
Monday, June 13, 2022FINAL REFUSAL WRITTEN
Monday, June 13, 2022FINAL REFUSAL E-MAILED
Monday, June 13, 2022NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, December 13, 2022TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, December 13, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 14, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 5, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 18, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 7, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 4, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 7, 2023PUBLISHED FOR OPPOSITION
Wednesday, October 4, 2023SOU EXTENSION 1 FILED
Wednesday, October 4, 2023SOU EXTENSION 1 GRANTED
Friday, October 6, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 4, 2023SOU TEAS EXTENSION RECEIVED
Thursday, April 4, 2024SOU TEAS EXTENSION RECEIVED
Thursday, April 4, 2024SOU EXTENSION 2 GRANTED
Thursday, April 4, 2024SOU EXTENSION 2 FILED
Tuesday, April 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 4, 2024SOU TEAS EXTENSION RECEIVED
Friday, April 4, 2025SOU TEAS EXTENSION RECEIVED
Friday, April 4, 2025SOU EXTENSION 4 FILED
Friday, April 4, 2025SOU EXTENSION 4 GRANTED
Friday, April 4, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 4, 2024SOU EXTENSION 3 FILED
Friday, October 4, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 4, 2024SOU EXTENSION 3 GRANTED

Related Keywords

immunopak antivirals glutathione amino stress synthesis oxidative reduction physiological medical acids